ULK1 Knockout Exacerbates Ischemia-Induced Microglial Dysfunction via TRAF6/NF-κB Signaling Pathway

Ye Xiong1, Zhuo Li Li2, Xiao Wan Wang2

  • 1Department of Neurosurgery, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, P.R. China.

PubMed

Insights

Unc-51-like autophagy activating kinase 1 (ULK1) regulates microglial activation and neuroinflammation in ischemic stroke. ULK1 deletion impairs myelin debris clearance, increasing pro-inflammatory responses via the TRAF6/NF-κB pathway.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglia play a crucial role in the acute phase of ischemic stroke by migrating to infarct sites, mediating neuroinflammation, and clearing debris.
  • The precise molecular mechanisms governing microglial activation and their inflammatory responses post-ischemic stroke are not fully understood.

Purpose of the Study:

  • To investigate the role of unc-51-like autophagy activating kinase 1 (ULK1) in regulating microglial activation and neuroinflammation during ischemic stroke.
  • To elucidate the signaling pathways involved in ULK1-mediated microglial responses.

Main Methods:

  • Utilized a cortical photothrombotic ischemic stroke model in mice.
  • Generated and analyzed unc-51-like autophagy activating kinase 1 (ULK1) knockout mice.
  • Performed co-immunoprecipitation assays to identify protein interactions.
  • Administered a tumor necrosis factor receptor-associated factor 6 (TRAF6) inhibitor in ischemic wild-type mice.

Main Results:

  • ULK1 knockout mice displayed increased pro-inflammatory microglia and elevated pro-inflammatory mediators.
  • ULK1 deletion impaired microglial phagocytosis of myelin debris, leading to myelin accumulation and heightened pro-inflammatory microglial activity.
  • ULK1 was found to bind to tumor necrosis factor receptor-associated factor 6 (TRAF6) in primary microglia.
  • Administration of a TRAF6 inhibitor modulated ULK1 and phosphorylated nuclear factor κ-B (p-NF-κB) protein levels in ischemic wild-type mice.

Conclusions:

  • ULK1 plays a significant role in controlling microglial activation and neuroinflammation following ischemic stroke.
  • ULK1 regulates these processes through interaction with TRAF6 and modulation of the TRAF6/NF-κB signaling pathway.
  • Targeting ULK1 may offer a therapeutic strategy for managing neuroinflammation in ischemic stroke.